LONDON--(BUSINESS WIRE)--Centauri Therapeutics Limited (Centauri), an immunotherapy company with a unique and proprietary platform technology applicable across a wide range of therapeutic indications, ...
Researchers from the National University of Singapore (NUS) have solved a 60-year-old mystery in bacterial cell envelope biology, defining the primary function of an important protein complex ...
New Delhi, Sep 2 (PTI) Patients with infections resistant to carbapenem — a powerful antibiotic often used as a last resort — ...
Expert Rev Anti Infect Ther. 2010;8(8):879-885. We recommend a thorough evaluation of patients with non-HACEK Gram-negative endocarditis to assess the necessity of surgical intervention. Decision to ...
In a recent study published in the journal Nature, researchers in the United States of America designed and discovered lolamicin, a selective antibiotic that targets the lipoprotein transport system ...
Japan-based Shionogi has received marketing authorisation from the Therapeutic Goods Administration (TGA) in Australia for ...
A major Indian study reveals alarming antibiotic resistance, especially to carbapenems, increasing death risk by up to 43% ...
Hosted on MSN
Pfizer introduces novel treatment option in UAE against Gram-negative bacterial infections
DUBAI, 18th November, 2025 (WAM) -- Pfizer announced the introduction of a novel treatment in the United Arab Emirates for adult patients with serious Gram-negative bacterial infections in the United ...
Add Yahoo as a preferred source to see more of our stories on Google. When you buy through links on our articles, Future and its syndication partners may earn a commission. Credit: Scharvik/Getty ...
Based on the Company's Alphamer® platform, the compound is designed to target serious Gram-negative bacterial infections in the lung, expanding therapeutic options for the most vulnerable patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results